{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:17:14Z","timestamp":1790965034316,"version":"4.1.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sexual Medicine Reviews"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.sxmr.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T09:18:11Z","timestamp":1523611091000},"page":"286-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["The History of Testosterone and the Evolution of its Therapeutic Potential"],"prefix":"10.1093","volume":"8","author":[{"given":"Abraham","family":"Morgentaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmaged","family":"Traish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"10.1016\/j.sxmr.2018.03.002_bib1","first-page":"42","article-title":"Transplantation der Hoden [Transplantation of testis]","volume":"16","author":"Berthold","year":"1849","journal-title":"Arch Anat Physiol Wiss"},{"key":"10.1016\/j.sxmr.2018.03.002_bib2","series-title":"The male hormone","author":"De Kruif","year":"1945"},{"key":"10.1016\/j.sxmr.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(00)64118-1","article-title":"The effects produced on man by subcutaneous injections of liquid obtained from the testicles of animals","volume":"2","author":"Brown-S\u00e9quard","year":"1889","journal-title":"Lancet"},{"key":"10.1016\/j.sxmr.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1353\/bhm.1999.0166","article-title":"New images of a new medicine: visual evidence for the widespread popularity of therapeutic discoveries in America after 1885","volume":"73","author":"Hansen","year":"1999","journal-title":"Bull Hist Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"678","DOI":"10.5694\/j.1326-5377.2002.tb05014.x","article-title":"Brown-S\u00e9quard revisited: a lesson from history of the placebo effect of androgen treatment","volume":"177","author":"Cussons","year":"2002","journal-title":"Med J Aust"},{"key":"10.1016\/j.sxmr.2018.03.002_bib6","first-page":"931","article-title":"Intratesticular testosterone concentrations comparable with serum levels are not sufficient to maintain normal sperm production in men receiving a hormonal contraceptive regimen","volume":"25","author":"Coviello","year":"2004","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2018.03.002_bib7","first-page":"242","article-title":"The effect of the injection of lipoid fraction of bull testicle in the capons","volume":"6","author":"McGee","year":"1927","journal-title":"Proc Inst Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/aja.1000450105","article-title":"Rat seminal-vesicle cytology as a testis-hormone indicator and the prevention of castration changes by testis-extract injection","volume":"45","author":"Moore","year":"1929","journal-title":"Am J Anat"},{"key":"10.1016\/j.sxmr.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/endo-13-4-367","article-title":"The effects of extracts of testis in correcting the castrated condition in the fowl and in the mammal","volume":"13","author":"Moore","year":"1929","journal-title":"Endocrinology"},{"key":"10.1016\/j.sxmr.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/aja.1000450104","article-title":"Rat-Prostate cytology as a testis-hormone indicator and the prevention of castration changes by testis-extract injections","volume":"45","author":"Moore","year":"1930","journal-title":"Am J Anat"},{"key":"10.1016\/j.sxmr.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0021-9258(18)77008-7","article-title":"The testicular hormone","volume":"84","author":"Gallagher","year":"1929","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.sxmr.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/aja.1000500104","article-title":"Cowper\u2019s gland and its reaction to castration and to different sex-hormone conditions","volume":"50","author":"Heller","year":"1932","journal-title":"Am J Anat"},{"key":"10.1016\/j.sxmr.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/bchm2.1935.233.5-6.281","article-title":"Crystalline male hormone from the testes (Testosterone) is more effective than androsterone derived from urine or cholesterin","volume":"233","author":"David","year":"1935","journal-title":"Hoppe-Seyler's Z physiol Chem"},{"key":"10.1016\/j.sxmr.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1515\/bchm2.1935.233.5-6.281","article-title":"\u00dcber krystallinisches mannliches Hormon aus Hoden (Testosteron) wirksamer als aus harn oder aus Cholesterin bereitetes Androsteron [On crystalline male hormone from testicles (testosterone) effective as from urine or from cholesterol]","volume":"233","author":"David","year":"1935","journal-title":"Hoppe Seyler Z Physiol Chem"},{"key":"10.1016\/j.sxmr.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/bchm2.1935.237.1-3.89","article-title":"[About testosterone. Conversion of dehydroandrosterones into androstenediol and testosterone; a way for the structure assignment of testosterone from cholesterol]","volume":"237","author":"Butenandt","year":"1935","journal-title":"Hoppe Seyler Z Physiol Chem"},{"key":"10.1016\/j.sxmr.2018.03.002_bib16","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/cber.19350680937","article-title":"[The conversion of dehydroandrosterone into androstenol-(17)-one-3 (testosterone); a method for the production of testosterone from cholesterol (preliminary communication)]","volume":"68","author":"Butenandt","year":"1935","journal-title":"Chem Berichte"},{"key":"10.1016\/j.sxmr.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/hlca.193501801176","article-title":"Uber die kristallinische Herstellung des Testikelhormons, Testosteron (Androsten-3-ol-17-ol) [The crystalline production of the testicle hormone, testosterone (androsten-3-ol-17-ol)]","volume":"18","author":"Ruzicka","year":"1935","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.sxmr.2018.03.002_bib18","first-page":"222","article-title":"Zur Therapie extragenitaler St\u00f6rungen mit Sexualhormonen","volume":"89","author":"Arndt","year":"1939","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.sxmr.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM194005232222104","article-title":"The use of testosterone","volume":"222","author":"Aub","year":"1940","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJM194303182281104","article-title":"Recent advances in testosterone therapy","volume":"228","author":"Aub","year":"1943","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1944.02850430006003","article-title":"The male climacteric, its symptomatology, diagnosis and treatment: use of urinary gonadotropins, therapeutic test with testosterone propionate and testicular biopsies in delineating the male climacterics from psychoneurosis and psychogenic impotence","volume":"126","author":"Heller","year":"1944","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1210\/jcem-5-10-412","article-title":"Testosterone propionate in treatment of senile pruritus","volume":"5","author":"Dobes","year":"1945","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000441-194607000-00002","article-title":"Testosterone in angina pectoris","volume":"1","author":"Levine","year":"1946","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.sxmr.2018.03.002_bib24","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1210\/jcem-6-8-549","article-title":"Testosterone propionate therapy in one hundred cases of angina pectoris","volume":"6","author":"Lesser","year":"1946","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.sxmr.2018.03.002_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0140-6736(47)91901-6","article-title":"Hypopituitarism, hypogonadism, and anaemia treated with testosterone","volume":"1","author":"Watkinson","year":"1947","journal-title":"Lancet"},{"key":"10.1016\/j.sxmr.2018.03.002_bib26","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1056\/NEJM194812302392704","article-title":"The use of testosterone in the treatment of depressions","volume":"239","author":"Altschule","year":"1948","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib27","first-page":"11","article-title":"Testosterone propionate in the treatment of renal failure","volume":"16","author":"Freedman","year":"1957","journal-title":"Clin Sci"},{"key":"10.1016\/j.sxmr.2018.03.002_bib28","first-page":"587","article-title":"Pellet implantation of hormones in urology","volume":"47","author":"Kearns","year":"1942","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib29","first-page":"225","article-title":"The clinical application of testosterone","volume":"112","author":"Kearns","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib30","first-page":"1869","article-title":"Clinical experiments with androgens IV. A method of implantation of crystalline testosterone","volume":"113","author":"West","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib31","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1001\/jama.1939.02800150013004","article-title":"The male climacteric","volume":"112","author":"Werner","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib32","first-page":"1949","article-title":"The present status of the testosterone propionate: three brands: Perandren, Oreton and Neo-homberol. (Roche-Organon) not acceptable for NNR. Council on Pharmacy and Chemistry","volume":"112","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1001\/jama.1942.02830290065032","article-title":"Council on Pharmacy and Chemistry (American Medical Association). Glandular physiology and therapy: a symposium prepared under the auspices of the Council on Pharmacy and Chemistry of the American Medical Association","volume":"119","year":"1942","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib34","first-page":"1970","article-title":"Sex hormones hold the stage","volume":"112","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib35","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1001\/jama.1939.02800190084020","article-title":"Current Comment: \u201cSex Hormones Hold the Stage.\u201d","volume":"112","author":"Fishbein","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib36","first-page":"293","article-title":"Studies on prostatic cancer, I: the effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"1","author":"Huggins","year":"1941","journal-title":"Cancer Res"},{"key":"10.1016\/j.sxmr.2018.03.002_bib37","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4103\/1008-682X.122358","article-title":"Testosterone deficiency: a historical perspective","volume":"16","author":"Nieschlag","year":"2014","journal-title":"Asian J Androl"},{"key":"10.1016\/j.sxmr.2018.03.002_bib38","first-page":"1178","article-title":"The long and tortuous history of the discovery of testosterone and its clinical application","volume":"10","author":"Morales","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib39","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/scientificamerican0295-76","article-title":"The history of synthetic testosterone","volume":"272","author":"Hoberman","year":"1995","journal-title":"Sci Am"},{"key":"10.1016\/j.sxmr.2018.03.002_bib40","first-page":"371","article-title":"A\u00a0brief history of testosterone","volume":"165","author":"Freeman","year":"2001","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib41","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1210\/endo-26-1-26","article-title":"A\u00a0comparative study of the metabolic effects of testosterone propionate in normal men and women and in eunuchoidism","volume":"26","author":"Kenyon","year":"1940","journal-title":"Endocrinology"},{"key":"10.1016\/j.sxmr.2018.03.002_bib42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0039-128X(99)00003-3","article-title":"The steroid story of Jenapharm: from the late 1940s to the early 1970s","volume":"64","author":"Schwarz","year":"1999","journal-title":"Steroids"},{"key":"10.1016\/j.sxmr.2018.03.002_bib43","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/endo-28-1-119","article-title":"Cutaneous vascular and pigmentary changes in castrate and eunuchoid men","volume":"28","author":"Edwards","year":"1941","journal-title":"Endocrinology"},{"key":"10.1016\/j.sxmr.2018.03.002_bib44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJM194207092270202","article-title":"Therapeutic evaluation of testosterone in peripheral vascular disease","volume":"227","author":"Beaser","year":"1942","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib45","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJM193905252202103","article-title":"Testosterone propionate as therapeutic agent in patients with organic disease of the peripheral vessels","volume":"220","author":"Edwards","year":"1939","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib46","first-page":"667","article-title":"The use of testosterone propionate and estrogenic substance in cardiovascular disease; preliminary report","volume":"34","author":"Walker","year":"1940","journal-title":"Med Rec Ann"},{"key":"10.1016\/j.sxmr.2018.03.002_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1210\/jcem-2-9-560","article-title":"The use of testosterone propionate and estrogenic substance in treatment of essential hypertension, angina pectoris and peripheral vascular disease","volume":"2","author":"Walker","year":"1942","journal-title":"J\u00a0Clin Endocrinol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib48","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/jcem-2-5-325","article-title":"Testosterone propionate in the treatment of angina pectoris","volume":"2","author":"Hamm","year":"1942","journal-title":"J\u00a0Clin Endocrinol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJM194201082260203","article-title":"The treatment of angina pectoris with testosterone propionate\u2014preliminary report","volume":"226","author":"Lesser","year":"1942","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM194302112280603","article-title":"The treatment of angina pectoris with testosterone propionate\u2014further observations","volume":"228","author":"Lesser","year":"1943","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib51","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM194311182292102","article-title":"The therapeutic value of testosterone propionate in angina pectoris","volume":"229","author":"Levine","year":"1943","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib52","first-page":"1424","article-title":"Treatment of angina pectoris by testosterone","volume":"43","author":"Sigler","year":"1943","journal-title":"N\u00a0Y State J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib53","first-page":"30","article-title":"Treatment of angina pectoris and peripheral vascular disease with sex hormones","volume":"50","author":"Strong","year":"1944","journal-title":"CMAJ"},{"key":"10.1016\/j.sxmr.2018.03.002_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1210\/jcem-5-7-305","article-title":"The treatment of angina pectoris with testosterone propionate","volume":"5","author":"Waldman","year":"1945","journal-title":"J\u00a0Clin Endocrinol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib55","first-page":"554","article-title":"Treatment of angina pectoris and coronary artery disease with sex hormones","volume":"37","author":"Bonnell","year":"1941","journal-title":"Ohio State Med J"},{"key":"10.1016\/j.sxmr.2018.03.002_bib56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/jcem-3-2-71","article-title":"Angina-like pain; a manifestation of the male climacterium","volume":"3","author":"McGavack","year":"1943","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib57","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/cne.901880202","article-title":"3H-oestradiol, 3H-testosterone and 3H-dihydrotestosterone localization in the brain of the lizard Anolis carolinensis: an autoradiograph study","volume":"188","author":"Morrell","year":"1979","journal-title":"J\u00a0Comp Neur"},{"key":"10.1016\/j.sxmr.2018.03.002_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1677\/joe.0.0820373","article-title":"Effects of intracranial implantation of oestradiol and dihydrotestosterone on the sexual behaviour of the lizard Anolis carolinensis","volume":"82","author":"Crews","year":"1979","journal-title":"J\u00a0Endocrinol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib59","first-page":"372","article-title":"The response of metastatic adenocarcinoma of the prostate to exogenous testosterone","volume":"126","author":"Fowler","year":"1981","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib60","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.1996.03540230054035","article-title":"Incidence of occult prostate cancer among men with low total or free serum testosterone","volume":"276","author":"Morgentaler","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib61","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.urology.2006.08.1058","article-title":"Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen of 4.0 ng\/ml or less","volume":"68","author":"Morgentaler","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.sxmr.2018.03.002_bib62","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJMra022251","article-title":"Risks of testosterone-replacement therapy and recommendations for monitoring","volume":"350","author":"Rhoden","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib63","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djm323","article-title":"Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies","volume":"100","author":"Roddam","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.sxmr.2018.03.002_bib64","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2006.06.034","article-title":"Testosterone and prostate cancer: an historical perspective on a modern myth","volume":"50","author":"Morgentaler","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.eururo.2008.09.024","article-title":"Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth","volume":"55","author":"Morgentaler","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib66","first-page":"2818","article-title":"Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months","volume":"11","author":"Morgentaler","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib67","first-page":"1005","article-title":"Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory","volume":"186","author":"Khera","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib68","first-page":"1256","article-title":"Testosterone therapy in men with untreated prostate cancer","volume":"185","author":"Morgentaler","year":"2011","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib69","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4103\/1008-682X.160270","article-title":"Can testosterone therapy be offered to men on active surveillance for prostate cancer? Preliminary results","volume":"18","author":"Kacker","year":"2016","journal-title":"Asian J Androl"},{"key":"10.1016\/j.sxmr.2018.03.002_bib70","first-page":"1082","article-title":"Testosterone therapy in patients with treated and untreated prostate cancer: impact on oncologic outcomes","volume":"196","author":"Ory","year":"2016","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib71","doi-asserted-by":"crossref","first-page":"269ra2","DOI":"10.1126\/scitranslmed.3010563","article-title":"Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: results from a pilot clinical study","volume":"7","author":"Schweizer","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib72","first-page":"71","article-title":"Androgen therapy in advanced carcinoma of the prostate","volume":"105","author":"Morales","year":"1971","journal-title":"CMAJ"},{"key":"10.1016\/j.sxmr.2018.03.002_bib73","first-page":"1319","article-title":"Diagnosing impotence","volume":"29","author":"Morales","year":"1983","journal-title":"Can Fam Physician"},{"key":"10.1016\/j.sxmr.2018.03.002_bib74","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2605.1982.tb00251.x","article-title":"Current status of testosterone substitution therapy","volume":"5","author":"Nieschlag","year":"1982","journal-title":"Int J Androl"},{"key":"10.1016\/j.sxmr.2018.03.002_bib75","first-page":"10","article-title":"The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction","volume":"30","author":"Traish","year":"2009","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2018.03.002_bib76","first-page":"23","article-title":"The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance","volume":"30","author":"Traish","year":"2009","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2018.03.002_bib77","first-page":"477","article-title":"The dark side of testosterone deficiency: III. Cardiovascular disease","volume":"30","author":"Traish","year":"2009","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.sxmr.2018.03.002_bib78","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib79","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1001\/jama.2013.280386","article-title":"Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels","volume":"310","author":"Vigen","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.sxmr.2018.03.002_bib80","first-page":"624","article-title":"Death by testosterone? We think not!","volume":"11","author":"Traish","year":"2014","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib81","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/eurheartj\/ehv346","article-title":"Normalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in men","volume":"36","author":"Sharma","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.sxmr.2018.03.002_bib82","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","volume":"4","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.sxmr.2018.03.002_bib83","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/1074248417691136","article-title":"Long-term testosterone therapy improves cardiometabolic function and reduces risk of cardiovascular disease in men with hypogonadism: a real-life observational registry study setting comparing treated and untreated (control) groups","volume":"22","author":"Traish","year":"2017","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.sxmr.2018.03.002_bib84","first-page":"272","article-title":"Testosterone and metabolic syndrome: a meta-analysis study","volume":"8","author":"Corona","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.sxmr.2018.03.002_bib85","doi-asserted-by":"crossref","first-page":"11","DOI":"10.15252\/embr.201643642","article-title":"Overselling hysteria: the role of the media and medical journals in promoting questionable risks\u2014a case study of the testosterone controversy","volume":"18","author":"Traish","year":"2017","journal-title":"EMBO Rep"},{"key":"10.1016\/j.sxmr.2018.03.002_bib86","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.mayocp.2016.04.007","article-title":"Fundamental concepts regarding testosterone deficiency and treatment: international expert consensus resolutions","volume":"9","author":"Morgentaler","year":"2016","journal-title":"Mayo Clin Proc"}],"container-title":["Sexual Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052118300404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2050052118300404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,1,3]],"date-time":"2023-01-03T14:37:38Z","timestamp":1672756658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2050052118300404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":86,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2050052118300404"],"URL":"https:\/\/doi.org\/10.1016\/j.sxmr.2018.03.002","relation":{},"ISSN":["2050-0521"],"issn-type":[{"value":"2050-0521","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The History of Testosterone and the Evolution of its Therapeutic Potential","name":"articletitle","label":"Article Title"},{"value":"Sexual Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sxmr.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}